IL33 and psoriasis: It has also been shown that IL-33 released from keratinocytes enhanced the transcription of genes encoding psoriasis-related cytokines, chemokines, and inflammatory molecules in keratinocytes in an autocrine manner (42, 43), suggesting that IL-33 is also a potential therapeutic target for psoriasis.